Beardsley Robert A — SEC insider filings
SEC reporting owner CIK 1310845. 10 insider filings on record with FilingPulse; latest filed 2026-10-07.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2021-01-28 to 2026-10-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Galera Therapeutics, Inc. (GRTX) | Chief Operating Officer | 6 | — | — | 9 |
| Arbutus Biopharma Corp (ABUS) | Director | 4 | — | — | 8 |
Insider filings — Beardsley Robert A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-07 | 4 | Arbutus Biopharma Corp (ABUS) | Disposition to issuer (D): 17,948 @ $5 | EDGAR |
| 2026-09-23 | 4 | Arbutus Biopharma Corp (ABUS) | Option exercise (M): 52,533 @ $3.20 · Option exercise (M): 78,800 @ $4.24 · Tax withholding (F): 99,057 @ $5.07 · Option exercise (M): 52,533 (derivative) @ $0 · Option exercise (M): 78,800 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Arbutus Biopharma Corp (ABUS) | Grant/award (A): 78,800 (derivative) @ $0 | EDGAR |
| 2025-03-20 | 4 | Arbutus Biopharma Corp (ABUS) | Grant/award (A): 157,600 (derivative) @ $0 | EDGAR |
| 2023-02-28 | 4 | Galera Therapeutics, Inc. (GRTX) | Grant/award (A): 135,000 (derivative) @ $0 | EDGAR |
| 2022-11-22 | 4 | Galera Therapeutics, Inc. (GRTX) | Option exercise (M): 10,000 @ $1.07 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2022-09-13 | 4 | Galera Therapeutics, Inc. (GRTX) | Option exercise (M): 10,000 @ $1.07 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Galera Therapeutics, Inc. (GRTX) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2021-12-20 | 4 | Galera Therapeutics, Inc. (GRTX) | Option exercise (M): 20,000 @ $1.07 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2021-01-28 | 4 | Galera Therapeutics, Inc. (GRTX) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1310845 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs